Edwards Lifesciences (EW) EBIAT (2016 - 2025)
Historic EBIAT for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $293.1 million.
- Edwards Lifesciences' EBIAT fell 9045.53% to $293.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 6678.21%. This contributed to the annual value of $4.2 billion for FY2024, which is 19767.54% up from last year.
- Edwards Lifesciences' EBIAT amounted to $293.1 million in Q3 2025, which was down 9045.53% from $337.6 million recorded in Q2 2025.
- Edwards Lifesciences' 5-year EBIAT high stood at $3.1 billion for Q3 2024, and its period low was $293.1 million during Q3 2025.
- In the last 5 years, Edwards Lifesciences' EBIAT had a median value of $365.2 million in 2025 and averaged $505.2 million.
- As far as peak fluctuations go, Edwards Lifesciences' EBIAT soared by 69781.76% in 2024, and later tumbled by 9045.53% in 2025.
- Over the past 5 years, Edwards Lifesciences' EBIAT (Quarter) stood at $335.3 million in 2021, then grew by 18.82% to $398.4 million in 2022, then decreased by 7.15% to $369.9 million in 2023, then increased by 4.24% to $385.6 million in 2024, then fell by 23.99% to $293.1 million in 2025.
- Its last three reported values are $293.1 million in Q3 2025, $337.6 million for Q2 2025, and $365.2 million during Q1 2025.